Jones Day is particularly proficient in multi-jurisdictional patent litigation in the life sciences sector, and is well equipped to advise clients on a breadth of intellectual property mandates, including breach of confidence issues, copyright and transactional work. Lisa Taliadoros leads the team from Melbourne while Samin Raihan’s practice encompasses high-value trade mark and patent disputes. All of the individuals mentioned are located in Sydney, unless stated otherwise. Since publication, Anthony Muratore retired.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Their biotech patent and pharmaceutical patent capability is foremost.’
- ‘They will go to the ends of the earth to obtain a good outcome for their client.’
- ‘They have been involved in many high-profile biotechnology/life sciences cases and have many years of patent litigation experience.’
- ‘Lisa Taliadoros has a deep scientific knowledge and is enormously committed.’
- ‘Lisa Taliadoros does not shy away from complex technical issues and arguments and will go the extra mile to ensure that the scientific and technical points are bottomed out.’
- ‘Jones Day has a strong IP litigation practice in the Australian market. The team is headed by Lisa Taliadoros, a veteran litigator with a technical background. She is accompanied by Tony Muratore who is very experienced litigator.’
- ‘Lisa Taliadoros has unparalleled biotech and pharma patent knowledge, and Tony Muratore is a highly experienced litigator.’
- ‘Both Lisa Taliadoros and Tony Muratore are not afraid to get stuck into the technical details working closely with experts.’
Key clients
- Celgene Corporation
- Bristol Myers Squibb
- ToolGen, Inc
- Sanofi
- Organon Pharma Pty Limited
- Merck Sharp & Dohme LLC and Merck Sharp & Dohme (Australia) Pty Ltd
- Chevron Corporation
Work highlights
- Acting for Celgene in relation to the enforcement and defence of patent rights relating to Revlimid and Pomalyst in proceedings against Juno Pharmaceuticals Pty Ltd and Natco Pharma Limited.
- Acting for Bristol Myers Squibb, an American global pharmaceutical company in an opposition in the Australian Patent Office to Australian Patent Application No. 2015292889.
- Acting for ToolGen in Federal Court proceedings concerning the validity of its patent rights to the revolutionary CRISPR gene editing technology.
Practice head
The lawyer(s) leading their teams.
Lisa Taliadoros